1. Introduction
===============

In our research on the chemical constituents of the marine invertebrates collected in Taiwan waters, a series of briarane-type diterpenoid derivatives had been isolated from various octocorals belonging to the genus *Briareum* (family Briareidae), *Ellisella*, and *Junceella* (family Ellisellidae), and the compounds of this type were proven to possess various interesting bioactivities \[[@b1-marinedrugs-08-02639]--[@b3-marinedrugs-08-02639]\]. Recently, our further chemical examination of *Briareum excavatum* has resulted in the isolation of two new highly oxidized briarane-type diterpenoids, excavatoids O (**1**) and P (**2**) ([Scheme 1](#f3-marinedrugs-08-02639){ref-type="fig"}). The structures of compounds **1** and **2** were established by spectroscopic methods.

2. Results and Discussion
=========================

Excavatoid O (**1**) was obtained as a white powder and had a molecular formula C~30~H~42~O~13~, as determined by HRESIMS (C~30~H~42~O~13~ + Na, *m/z* found 633.2519; calculated 633.2523) indicating 10 degrees of unsaturation. The presence of hydroxy, lactone, and ester groups in **1** were evidenced by the IR absorptions at 3512, 1793, and 1741 cm^−1^. It was found that the ^1^H and ^13^C spectra of **1** in CDCl~3~ revealed mostly broad peaks when measured at 25 °C. In order to make more reliable assignments of NMR signals of the stabilized conformers, the ^1^H and ^13^C NMR spectra of **1** were measured at 0 °C in CDCl~3~. In the ^13^C spectrum of **1**, five ester carbonyl resonances appeared at *δ*~C~ 173.6, 170.8, 170.1, 169.5, and 169.3 (5 × s) ([Table 1](#t1-marinedrugs-08-02639){ref-type="table"}). In the above carbonyl carbons, three were identified as acetate carbonyls by the presence of three methyl resonances in the ^1^H NMR spectrum at *δ*~H~ 2.18, 2.12, and 1.96 (each 3H × s) and one was identified as *n*-butyrate carbonyl by the presence of seven contiguous protons at *δ*~H~ 0.95 (3H, t, *J* = 7.2 Hz), 1.64 (2H, m), and 2.23 (2H, m) ([Table 1](#t1-marinedrugs-08-02639){ref-type="table"}). On the basis of the unsaturation data overall, **1** was concluded to be a briarane diterpenoid molecule possessing five rings. A tetra-substituted epoxide containing a methyl substituent was elucidated from the signals of two oxygenated quaternary carbons at *δ*~C~ 72.6 (s, C-8) and 63.3 (s, C-17); and further confirmed by the proton signal of a methyl singlet at *δ*~H~ 1.57 (3H, s, H~3~-18). In addition, a tri-substituted epoxide containing a methyl substituent was deduced from the signals of an oxymethine (*δ*~H~ 3.11, 1H, d, *J* = 8.8 Hz, H-6; *δ*~C~ 63.0, d, C-6), a quaternary oxygen-bearing carbon (*δ*~C~ 62.1, s, C-5), and a methyl singlet at δ~H~ 1.35 (3H, s, H~3~-16).

From the ^1^H-^1^H COSY experiment of **1** ([Table 2](#t2-marinedrugs-08-02639){ref-type="table"}), it was possible to establish the separate spin systems that map out the proton sequences from H-2/H-3/H~2~-4, H-6/H-7, and H-9/H-10. These data, together with the HMBC correlations between H-2/C-1, -4; H-3/C-4; H~2~-4/C-3, -5, -6; H-7/C-5, -6; H-9/C-1, -7, -8, -10; and H-10/C-1, -2, established the connectivity from C-1 to C-10 in the 10-membered ring ([Table 2](#t2-marinedrugs-08-02639){ref-type="table"}). The methyl group at C-5 was confirmed by the HMBC correlations between H~3~-16/C-4, -5, -6. The methylcyclohexane ring, which is fused to the 10-membered ring at C-1 and C-10, was elucidated by the ^1^H-^1^H COSY correlations between H-10/H-11/H-12/H~2~-13/H-14 and H-11/H~3~-20 and by the HMBC correlations between H-2/C-14; H-9/C-11; H-10/C-11, -12, -14; H-11/C-10, -20; H~2~-13/C-1; H-14/C-1, -2; and H~3~-20/C-10, -11, -12. The ring junction C-15 methyl group was positioned at C-1 from the HMBC correlations between H-2/C-15; and H~3~-15/C-1, -2, -10, -14. In addition, the HMBC correlations also revealed that three acetates should be attached at C-2, C-9, and C-14, respectively. The remaining *n*-butyrate ester and hydroxy groups were positioned at C-3 and C-12 as indicated by analysis of ^1^H-^1^H COSY correlations and characteristic NMR signals analysis (*δ*~H~ 5.13, 1H, br s, H-3; *δ*~C~ 69.9, d, C-3; *δ*~H~ 3.96, 1H, br s, H-12; *δ*~C~ 69.3, d, C-12). These data, together with the HMBC correlations between H-7/C-17, -19 and H~3~-18/C-8, -17, -19, were used to establish the molecular framework of **1**.

Based on previous studies, all naturally occurring briarane-type diterpenoids have the C-15 methyl group as *trans* to H-10, and these two groups are assigned as *β* - and *α*-oriented, respectively, as shown in most briarane derivatives \[[@b1-marinedrugs-08-02639]--[@b3-marinedrugs-08-02639]\]. The relative stereochemistry of **1** was established from a NOESY experiment ([Figure 1](#f1-marinedrugs-08-02639){ref-type="fig"}). In the NOESY experiment of **1**, the correlations of H-10 with H-2, H-3, H-6, H-9, and H-11; and H-11 correlated with H-12, indicated that these protons are situated on the same face and were assigned as *α* protons since the C-15 methyl is the *β* -substituent at C-1. H-14 was found to exhibit a correlation with H~3~-15, revealing the *β* -orientation of this proton. The correlations between H~3~-16 and H-3, H-6, reflected the *α*-orientation of H~3~-16. H-7 correlated with H~3~-15, indicating this proton should be *β* -oriented. Furthermore, H~3~-18 showed a correlation with H-9. By detailed analysis of molecular models, H~3~-18 was found to be reasonably close to H-9 when H~3~-18 was placed on the *β* face in the *γ*-lactone moiety. Based on the above findings, the structure of **1** was elucidated unambiguously.

The molecular formula of excavatoid P (**2**) was determined as C~30~H~43~ClO~14~ by its HRESIMS (*m/z* 685.2235, calculated for C~30~H~43~ClO~14~ + Na, 685.2239). The IR spectrum showed bands at 3472, 1784, and 1734 cm^−1^, consistent with the presence of hydroxy, *γ*-lactone, and ester groups in **2**. From the ^13^C NMR data of **2** ([Table 1](#t1-marinedrugs-08-02639){ref-type="table"}), five carbonyl resonances appeared at *δ*~C~ 173.9, 172.0, 170.4, 170.3, and 170.0 (5 × s), confirming the presence of a *γ*-lactone and four esters in **2**; three acetyl methyls (*δ*~H~ 2.43, 2.17, 2.03, each 3H × s) and an *n*-butyryl group (*δ*~H~ 0.98, 3H, t, *J* = 7.6 Hz; 1.66, 2H, m; 2.33, 2H, t, *J* = 7.6 Hz) were also observed. According to the above data, briarane **2** was found to be a tetracyclic compound with a *γ*-lactone, as no other unsaturated functional group could be found.

^1^H NMR coupling information in the ^1^H-^1^H COSY spectrum of **2** enabled identification of the C-2/-3/-4, C-6/-7, C-9/-10/-11/-12/-13/-14, and C-11/-20 units ([Table 2](#t2-marinedrugs-08-02639){ref-type="table"}), which were assembled with the assistance of an HMBC experiment ([Table 2](#t2-marinedrugs-08-02639){ref-type="table"}). The HMBC correlations between protons and quaternary carbons, such as H-2, H-3, H-10, H-11, H~3~-15/C-1; H-3, H-4, H-6, H-7, H~3~-16, OH-5/C-5; H-6, H-9, H-10, H~3~-18/C-8; H-9, H~3~-18/C-17; and H-7, H~3~-18/C-19, permitted elucidation of the carbon skeleton. A methyl at C-5 was established by the HMBC correlations between H~3~-16/C-4, -5, -6 and H-4, H-6, OH-5/C-16. The ring junction C-15 methyl group was positioned at C-1 from the HMBC correlations between H~3~-15/C-1, -2, -10, -14; and H-10/C-15. The acetate esters at C-2 and C-9 were established by correlations between H-2 (*δ*~H~ 4.62), H-9 (*δ*~H~ 5.36) and the acetate carbonyls observed in the HMBC spectrum of **2**. The *n*-butyrate ester positioned at C-4 was confirmed from the HMBC correlation between H-4 (*δ*~H~ 5.82) and the carbonyl carbon (*δ*~C~ 173.9) of *n*-butyrate ester. Thus, the remaining acetoxy group was positioned at C-14 as indicated by analysis of ^1^H-^1^H COSY correlations and characteristic NMR signals (*δ*~H~ 4.84, 1H, br s, H-14; *δ*~C~ 80.8, d, C-14). The presence of hydroxy groups at C-3 and C-12 was deduced from the ^1^H-^1^H COSY correlations between the hydroxy protons (*δ*~H~ 3.18, OH-3 and *δ*~H~ 2.17, OH-12) and H-3 (*δ*~H~ 5.07) and H-12 (*δ*~H~ 4.13), respectively. The C-5 hydroxy group was also confirmed by the HMBC correlations between the hydroxy proton (*δ*~H~ 2.36, OH-5) and C-4, -5, -16. Thus, the remaining chlorine atom in **2** should be attached C-6 by the ^1^H-^1^H COSY correlation between H-6 (*δ*~H~ 4.29) and H-7 (*δ*~H~ 5.26) and further supported by the HMBC correlations between H-6/C-4, -5, -7, -8, -16 and H-7, H~3~-16/C-6.

The relative configuration of **2** was elucidated from the interactions observed in a NOESY experiment and from vicinal proton coupling constant analysis. In the NOESY experiment of **2** ([Figure 2](#f2-marinedrugs-08-02639){ref-type="fig"}), the correlations of H-10 with H-3, H-11, and H-12, indicated that these protons were situated on the same face and were assigned as *α* protons since the C-15 and C-20 methyls are *β* -substituents at C-1 and C-11, respectively. H-2 exhibited an interaction with H-3, and no coupling was found between H-2 and H-3, indicating that the dihedral angle between H-2/H-3 is approximately 90° and the acetoxy group at C-2 should be *β* -oriented. H-14 was found to exhibit a response with H~3~-15, showing that H-14 has a *β* -orientation. H-9 was found to show responses with H-11, H~3~-18, and H~3~-20. From modeling analysis, H-9 was found to be close to H-11, H~3~-18, and H~3~-20 when H-9 was *α*-oriented. Moreover, H~3~-16 exhibited correlations with H-3 and H-6, and no coupling constant was detected between H-6 and H-7, suggesting the *α*-orientation of H~3~-16 and H-6; and *β*-orientation of H-7. H-7 exhibited a correlation with H-4, and no coupling was found between H-3 and H-4, indicating that the dihedral angle between H-3 and H-4 is also approximately 90° and the *n*-butyrate ester group at C-4 was *α*-oriented. On the basis of the above results, the structure of **2** was elucidated. To the best of our knowledge, briarane **2** is the first briarane which possesses a 6*β* -chlorine atom.

In the biological activity testing, briaranes **1** and **2** displayed 16.9 and 16.1% inhibitory effects on elastase release by human neutrophils at 10 μg/mL, resepectively \[[@b4-marinedrugs-08-02639]\].

3. Experimental
===============

3.1. General Experimental Procedures
------------------------------------

Melting points were determined on a FARGO apparatus and were uncorrected. Optical rotation values were measured with a JASCO P-1010 digital polarimeter at 25 °C. Infrared spectra were obtained on a VARIAN DIGLAB FTS 1000 FT-IR spectrometer. The NMR spectra were recorded on a VARIAN MERCURY PLUS 400 FT-NMR at 400 MHz for ^1^H and 100 MHz for ^13^C, in CDCl~3~, at 25 or 0 °C, respectively. Proton chemical shifts were referenced to the residual CHCl~3~ signal (*δ*~H~ 7.26 ppm). ^13^C NMR spectra were referenced to the center peak of CDCl~3~ at *δ*~C~ 77.1 ppm. ESIMS and HRESIMS data were recorded on a BRUKER APEX II mass spectrometer. Column chromatography was performed on silica gel (230--400 mesh, Merck, Darmstadt, Germany). TLC was carried out on precoated Kieselgel 60 F~254~ (0.25 mm, Merck) and spots were visualized by spraying with 10% H~2~SO~4~ solution followed by heating. HPLC was performed using a system comprised of a HITACHI L-7100 pump, a HITACHI photodiode array detector L-7455, and a RHEODYNE 7725 injection port. A normal phase column (Hibar 250 × 10 mm, Merck, silica gel 60, 5 μm,) was used for HPLC.

3.2. Animal Material
--------------------

Specimens of the octocoral *Briareum excavatum* were collected and transplanted in 0.6-ton cultivating tanks located in the NMMBA, Taiwan, in December 2003. This organism was identified by comparison with previous descriptions \[[@b5-marinedrugs-08-02639]--[@b7-marinedrugs-08-02639]\]. A voucher specimen was deposited in the National Museum of Marine Biology and Aquarium, Taiwan.

3.3. Extraction and Isolation
-----------------------------

The organism (wet weight 1.0 kg) was collected and freeze-dried. The freeze-dried material was minced and extracted with EtOAc. The extract was separated by silica gel column chromatography, using hexane and hexane/EtOAc mixtures of increased polarity to yield 12 fractions. Fraction 3 was separated by normal phase HPLC, using a mixture of dichloromethane and acetone to afford briarane **2** (0.9 mg, 9/1). Fraction 2 was separated by normal phase HPLC, using a mixture of hexane and EtOAc to afford briarane **1** (13.2 mg, 1/1).

Excavatoid O (**1**): white powder; mp 137--138 °C; \[*α*\]~D~^25^ − 39 (*c* 0.4, CHCl~3~); IR (neat) *ν*~max~ 3512, 1793, 1741 cm^−1^; ^13^C NMR (CDCl~3~, 100 MHz) and ^1^H NMR (CDCl~3~, 400 MHz) data, see [Table 1](#t1-marinedrugs-08-02639){ref-type="table"}; ESIMS *m/z* 633 (M + Na)^+^; HRESIMS *m/z* 633.2519 (Calcd for C~30~H~42~O~13~Na, 633.2523).

Excavatoid P (**2**): white powder; mp 154--155 °C; \[*α*\]~D~^25^ + 14 (*c* 0.05, CHCl~3~); IR (neat) *ν*~max~ 3472, 1784, 1734 cm^−1^; ^13^C NMR (CDCl~3~, 100 MHz) and ^1^H NMR (CDCl~3~, 400 MHz) data, see [Table 1](#t1-marinedrugs-08-02639){ref-type="table"}; ESIMS *m/z* 685 (M + Na)^+^; HRESIMS *m/z* 685.2235 (Calcd for C~30~H~43~ClO~14~Na, 685.2239).

3.4. Human Neutrophil Elastase Release
--------------------------------------

Human neutrophils were obtained by means of dextran sedimentation and Ficoll centrifugation. Elastase release experiments were performed using MeO-Suc-Ala-Ala-Pro-Valp-nitroanilide as the elastase substrate \[[@b8-marinedrugs-08-02639],[@b9-marinedrugs-08-02639]\].
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###### 

^1^H and ^13^C NMR data for diterpenoids **1** and **2**.

            1                                                                  2                                                                                   
  --------- ------------------------------------------------------------------ -------------------------------------------------------------- -------------------- -----------
  1                                                                            43.3 (s)[f](#tfn6-marinedrugs-08-02639){ref-type="table-fn"}                        44.0 (s)
  2         5.81 d (2.0)[e](#tfn5-marinedrugs-08-02639){ref-type="table-fn"}   69.3 (d)                                                       4.62 s               88.2 (d)
  3         5.13 br s                                                          69.9 (d)                                                       5.07 d (11.6)        68.8 (d)
  4         2.25 m (2H)                                                        33.7 (t)                                                       5.82 s               70.9 (d)
  5                                                                            62.1 (s)                                                                            77.8 (s)
  6         3.11 d (8.8)                                                       63.0 (d)                                                       4.29 s               65.9 (d)
  7         4.69 d (8.8)                                                       78.3 (d)                                                       5.26 s               75.7 (d)
  8                                                                            72.6 (s)                                                                            67.5 (s)
  9         5.76 s                                                             68.5 (d)                                                       5.36 d (8.4)         66.0 (d)
  10        2.18 br s                                                          45.3 (d)                                                       3.52 dd (8.4, 4.4)   39.5 (d)
  11        2.32 br s                                                          34.5 (d)                                                       2.54 m               37.3 (d)
  12        3.96 br s                                                          69.3 (d)                                                       4.13 m               66.9 (d)
  13        1.92 m (2H)                                                        34.8 (t)                                                       1.83 m (*α*)         30.3 (t)
                                                                                                                                              1.96 m (*β* )        
  14        5.16 br s                                                          73.0 (d)                                                       4.84 br s            80.8 (d)
  15        1.52 s                                                             18.2 (q)                                                       0.86 s               18.2 (q)
  16        1.35 s                                                             21.1 (q)                                                       1.55 s               22.3 (q)
  17                                                                           63.3 (s)                                                                            60.6 (s)
  18        1.57 s                                                             11.1 (q)                                                       1.63 s               10.0 (q)
  19                                                                           170.8 (s)                                                                           170.0 (s)
  20        1.19 d (7.2)                                                       16.3 (q)                                                       1.11 d (7.6)         9.0 (q)
  OH-3                                                                                                                                        3.18 d (11.6)        
  OH-5                                                                                                                                        2.36 s               
  OH-12     n.o.[g](#tfn7-marinedrugs-08-02639){ref-type="table-fn"}                                                                          2.17 br s            
  2-OAc                                                                        169.5 (s)                                                                           172.0 (s)
            2.12 s                                                             21.1 (q)                                                       2.03 s               21.1 (q)
  9-OAc                                                                        169.3 (s)                                                                           170.4 (s)
            2.18 s                                                             21.2 (q)                                                       2.43 s               21.4 (q)
  14-OAc                                                                       170.1 (s)                                                                           170.3 (s)
            1.96 s                                                             21.1 (q)                                                       2.17 s               21.3 (q)
  3-OCOPr                                                                      173.6 (s)                                                                           
            2.23 m (2H)                                                        35.6 (t)                                                                            
            1.64 m (2H)                                                        17.8 (t)                                                                            
            0.95 t (7.2)                                                       13.6 (q)                                                                            
  4-OCOPr                                                                                                                                                          173.9 (s)
                                                                                                                                              2.33 t (7.6) (2H)    36.3 (t)
                                                                                                                                              1.66 m (2H)          18.4 (t)
                                                                                                                                              0.98 t (7.6)         13.7 (q)

Spectra were recorded at 400 MHz at 0 °C;

Spectra were recorded at 100 MHz at 0 °C;

Spectra were recorded at 400 MHz at 25 °C;

Spectra were recorded at 100 MHz at 25 °C;

*J* values (in Hz) in parentheses;

Multiplicity deduced by DEPT and HMQC spectra and indicated by usual symbols;

n.o. = not observed.

###### 

The ^1^H-^1^H COSY and HMBC (H→C) correlations for diterpenoids **1** and **2**.

          1                                                          2                                                               
  ------- ---------------------------------------------------------- ----------------------------------------- --------------------- ------------------------------------------
  H-2     H-3                                                        C-1, -4, -14, -15, acetate carbonyl       H-3                   C-1, -3, -4, -10, -14, acetate carbonyl
  H-3     H-2, H~2~-4                                                C-4                                       H-2, H-4, OH-3        C-1, -5
  H-4     H-3                                                        C-3, -5, -6                               H-3                   C-2, -5, -16, *n*-butyrate carbonyl
  H-6     H-7                                                        n.o.                                      H-7                   C-4, -5, -7, -8, -16
  H-7     H-6                                                        C-5, -6, -17, -19                         H-6                   C-5, -6, -9, -19
  H-9     H-10                                                       C-1, -7, -8, -10, -11, acetate carbonyl   H-10                  C-7, -8, -10, -11, -17, acetate carbonyl
  H-10    H-9, H-11                                                  C-1, -2, -11, -12, -14                    H-9, H-11             C-1, -8, -9, -11, -12, -15, -20
  H-11    H-10, H-12, H~3~-20                                        C-10, -20                                 H-10, H-12, H~3~-20   C-1, -10, -12, -20
  H-12    H-11, H~2~-13                                              n.o.                                      H-11, H~2~-13         C-20
  H-13    H-12, H-14                                                 C-1, -14                                  H-12, H-14            C-12
  H-14    H~2~-13                                                    C-1, -2, -12, -13, acetate carbonyl       H~2~-13               C-10, -12
  H-15                                                               C-1, -2, -10, -14                                               C-1, -2, -10, -14
  H-16                                                               C-4, -5, -6                                                     C-4, -5, -6
  H-18                                                               C-8, -17, -19                                                   C-8, -17, -19
  H-20    H-11                                                       C-10, -11, -12                            H-11                  C-10, -11, -12
  OH-3                                                                                                         H-3                   C-3
  OH-5                                                                                                                               C-4, -5, -16
  OH-12   n.o.[a](#tfn8-marinedrugs-08-02639){ref-type="table-fn"}   n.o.                                      H-12                  C-11

: n.o. = not observed.
